Trial intelligence / Profile preview

Randomised controlled trial of injectable opioid treatment for heroin dependence (RIOTT)

2004-003175-36Phase 3Completed

Sponsor
King's College London
Start
Sep 2006
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of methadone and diamorphine in opioid use disorder (OUD) (3 arms), sponsored by King's College London. Primary endpoint: treatment retention. Started Sep 2006; status: completed.

02

Drugs

methadonediamorphine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on 2004-003175-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-003175-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call